BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 32117713)

  • 41. [Differential analysis of gene expression profiles in hepatocellular carcinoma patients with high and low levels of alpha-fetoprotein].
    Wang XJ; Shen RF; Wang X; Wang YR; Xiao T
    Zhonghua Zhong Liu Za Zhi; 2020 May; 42(5):396-402. PubMed ID: 32482029
    [No Abstract]   [Full Text] [Related]  

  • 42. Identification of survival-related predictors in hepatocellular carcinoma through integrated genomic, transcriptomic, and proteomic analyses.
    Dong F; Yang Q; Wu Z; Hu X; Shi D; Feng M; Li J; Zhu L; Jiang S; Bao Z
    Biomed Pharmacother; 2019 Jun; 114():108856. PubMed ID: 30981109
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Screening and bioinformatics analysis of circular RNA expression profiles in hepatitis B-related hepatocellular carcinoma.
    Wang S; Cui S; Zhao W; Qian Z; Liu H; Chen Y; Lv F; Ding HG
    Cancer Biomark; 2018; 22(4):631-640. PubMed ID: 29914004
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Clinical Significance of microRNA-196b-5p in Hepatocellular Carcinoma and its Potential Molecular Mechanism.
    Zhang L; Luo B; Dang YW; He RQ; Peng ZG; Chen G; Feng ZB
    J Cancer; 2019; 10(22):5355-5370. PubMed ID: 31632480
    [No Abstract]   [Full Text] [Related]  

  • 45. Critical genes of hepatocellular carcinoma revealed by network and module analysis of RNA-seq data.
    Yang MR; Zhang Y; Wu XX; Chen W
    Eur Rev Med Pharmacol Sci; 2016 Oct; 20(20):4248-4256. PubMed ID: 27831650
    [TBL] [Abstract][Full Text] [Related]  

  • 46. RNA over-editing of BLCAP contributes to hepatocarcinogenesis identified by whole-genome and transcriptome sequencing.
    Hu X; Wan S; Ou Y; Zhou B; Zhu J; Yi X; Guan Y; Jia W; Liu X; Wang Q; Qi Y; Yuan Q; Huang W; Liao W; Wang Y; Zhang Q; Xiao H; Chen X; Huang J
    Cancer Lett; 2015 Feb; 357(2):510-9. PubMed ID: 25499081
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Global RNA editing identification and characterization during human pluripotent-to-cardiomyocyte differentiation.
    Chen J; Liu HF; Qiao LB; Wang FB; Wang L; Lin Y; Liu J
    Mol Ther Nucleic Acids; 2021 Dec; 26():879-891. PubMed ID: 34760335
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Upregulation of CENPM promotes hepatocarcinogenesis through mutiple mechanisms.
    Xiao Y; Najeeb RM; Ma D; Yang K; Zhong Q; Liu Q
    J Exp Clin Cancer Res; 2019 Nov; 38(1):458. PubMed ID: 31703591
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Diagnostic value of strand-specific miRNA-101-3p and miRNA-101-5p for hepatocellular carcinoma and a bioinformatic analysis of their possible mechanism of action.
    Yang X; Pang YY; He RQ; Lin P; Cen JM; Yang H; Ma J; Chen G
    FEBS Open Bio; 2018 Jan; 8(1):64-84. PubMed ID: 29321958
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Comprehensive molecular and immunological characterization of hepatocellular carcinoma.
    Shimada S; Mogushi K; Akiyama Y; Furuyama T; Watanabe S; Ogura T; Ogawa K; Ono H; Mitsunori Y; Ban D; Kudo A; Arii S; Tanabe M; Wands JR; Tanaka S
    EBioMedicine; 2019 Feb; 40():457-470. PubMed ID: 30598371
    [TBL] [Abstract][Full Text] [Related]  

  • 51. MiR-107 suppresses proliferation of hepatoma cells through targeting HMGA2 mRNA 3'UTR.
    Wang Y; Chen F; Zhao M; Yang Z; Zhang S; Ye L; Gao H; Zhang X
    Biochem Biophys Res Commun; 2016 Nov; 480(3):455-460. PubMed ID: 27773820
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Global profiling of alternative RNA splicing events provides insights into molecular differences between various types of hepatocellular carcinoma.
    Tremblay MP; Armero VE; Allaire A; Boudreault S; Martenon-Brodeur C; Durand M; Lapointe E; Thibault P; Tremblay-Létourneau M; Perreault JP; Scott MS; Bisaillon M
    BMC Genomics; 2016 Aug; 17(1):683. PubMed ID: 27565572
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The DNA methylation profile of liver tumors in C3H mice and identification of differentially methylated regions involved in the regulation of tumorigenic genes.
    Matsushita J; Okamura K; Nakabayashi K; Suzuki T; Horibe Y; Kawai T; Sakurai T; Yamashita S; Higami Y; Ichihara G; Hata K; Nohara K
    BMC Cancer; 2018 Mar; 18(1):317. PubMed ID: 29566670
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Identification of Potential Prognostic Long Non-Coding RNA Biomarkers for Predicting Survival in Patients with Hepatocellular Carcinoma.
    Liao X; Yang C; Huang R; Han C; Yu T; Huang K; Liu X; Yu L; Zhu G; Su H; Wang X; Qin W; Deng J; Zeng X; Ye X; Peng T
    Cell Physiol Biochem; 2018; 48(5):1854-1869. PubMed ID: 30092592
    [TBL] [Abstract][Full Text] [Related]  

  • 55. CADM2, as a new target of miR-10b, promotes tumor metastasis through FAK/AKT pathway in hepatocellular carcinoma.
    Li D; Zhang Y; Zhang H; Zhan C; Li X; Ba T; Qiu Z; E F; Lv G; Zou C; Wang C; Si L; Zou C; Li Q; Gao X
    J Exp Clin Cancer Res; 2018 Mar; 37(1):46. PubMed ID: 29506532
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The Cancer Editome Atlas: A Resource for Exploratory Analysis of the Adenosine-to-Inosine RNA Editome in Cancer.
    Lin CH; Chen SC
    Cancer Res; 2019 Jun; 79(11):3001-3006. PubMed ID: 31015229
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Hypermethylation of NF-κB-Activating Protein-Like (NKAPL) Promoter in Hepatocellular Carcinoma Suppresses Its Expression and Predicts a Poor Prognosis.
    Ng PKS; Lau CPY; Lam EKY; Li SSK; Lui VWY; Yeo W; Ng YK; Lai PBS; Tsui SKW
    Dig Dis Sci; 2018 Mar; 63(3):676-686. PubMed ID: 29353445
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Comprehensive analysis of long non-coding RNA PVT1 gene interaction regulatory network in hepatocellular carcinoma using gene microarray and bioinformatics.
    Zhang Y; Dang YW; Wang X; Yang X; Zhang R; Lv ZL; Chen G
    Am J Transl Res; 2017; 9(9):3904-3917. PubMed ID: 28979669
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Prognostic value of ubiquitin-conjugating enzyme E2 S overexpression in hepatocellular carcinoma.
    Ma Y; Li K; Li S; Liang B; Liu Q; Mo Z
    Int J Biol Macromol; 2018 Nov; 119():225-231. PubMed ID: 30041036
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Systematic characterization of A-to-I RNA editing hotspots in microRNAs across human cancers.
    Wang Y; Xu X; Yu S; Jeong KJ; Zhou Z; Han L; Tsang YH; Li J; Chen H; Mangala LS; Yuan Y; Eterovic AK; Lu Y; Sood AK; Scott KL; Mills GB; Liang H
    Genome Res; 2017 Jul; 27(7):1112-1125. PubMed ID: 28411194
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.